Skip to main content

Table 2 Changes in primary and secondary outcome variables

From: A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood

Variable Triheptanoin Placebo p value
Total paroxysmal events 3.5 (2.1) 3.2 (2.1) 0.646
Motor-epilepticparoxysmal events 3.4 (1.9) 3.2 (2.0) 0.585
Composite score 1015 (1058) 723.9 (767.3) 0.059
CGI – patient 3.7 (1.5) 3.2 (1.0) 0.481
CGI – physician 3.8 (0.6) 3.3 (0.9) 0.262
  1. Values are means (standard deviation). Total and motor-epileptic paroxysmal events are expressed per week. Wilcoxon test for the difference in changes on each treatment. Abbreviations: CGI Clinical Global Impression-Improvement scale